메뉴 건너뛰기




Volumn 25, Issue 10, 2015, Pages 959-967

Medication is an additional source of phosphate intake in chronic kidney disease patients

Author keywords

Cardiovascular risk; Chronic kidney disease; Drugs; Observational study; Phosphate

Indexed keywords

INSULIN; PHOSPHATE; PHOSPHATE CONTAINING MEDICINAL PRODUCT; SEX HORMONE; UNCLASSIFIED DRUG; URINARY TRACT AGENT; CARDIOVASCULAR AGENT; GASTROINTESTINAL AGENT; PRESCRIPTION DRUG;

EID: 84941943427     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.06.001     Document Type: Article
Times cited : (13)

References (24)
  • 1
    • 80052561697 scopus 로고    scopus 로고
    • Arterial calcification in chronic kidney disease: key roles for calcium and phosphate
    • Shanahan C.M., Crouthamel M.H., Kapustin A., Giachelli C.M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011, 109(6):697-711.
    • (2011) Circ Res , vol.109 , Issue.6 , pp. 697-711
    • Shanahan, C.M.1    Crouthamel, M.H.2    Kapustin, A.3    Giachelli, C.M.4
  • 2
    • 0033645994 scopus 로고    scopus 로고
    • Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure
    • Fouque D., Wang P., Laville M., Boissel J.P. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant 2000, 15(12):1986-1992.
    • (2000) Nephrol Dial Transplant , vol.15 , Issue.12 , pp. 1986-1992
    • Fouque, D.1    Wang, P.2    Laville, M.3    Boissel, J.P.4
  • 3
    • 51249095394 scopus 로고    scopus 로고
    • High phosphate content beverages in dialysis patients: relevance for hyperphosphatemia and cardiovascular risk
    • Savica V., Calò L.A., Monardo P., Caldarera R., Cavaleri A., Santoro D., et al. High phosphate content beverages in dialysis patients: relevance for hyperphosphatemia and cardiovascular risk. Nutr Metab Cardiovasc Dis 2008, 18(8):e39-40.
    • (2008) Nutr Metab Cardiovasc Dis , vol.18 , Issue.8 , pp. e39-e40
    • Savica, V.1    Calò, L.A.2    Monardo, P.3    Caldarera, R.4    Cavaleri, A.5    Santoro, D.6
  • 4
    • 33749998907 scopus 로고    scopus 로고
    • Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources
    • UVEC Group
    • Trifirò G., Corrao S., Alacqua M., Moretti S., Tari M., Caputi A.P., et al. Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources. Br J Clin Pharmacol 2006, 62(5):582-590. UVEC Group.
    • (2006) Br J Clin Pharmacol , vol.62 , Issue.5 , pp. 582-590
    • Trifirò, G.1    Corrao, S.2    Alacqua, M.3    Moretti, S.4    Tari, M.5    Caputi, A.P.6
  • 5
    • 46949106028 scopus 로고    scopus 로고
    • Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005
    • Trifirò G., Savica R., Morgante L., Vanacore N., Tari M., Moretti S., et al. Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005. Park Relat Disord 2008, 14(5):420-425.
    • (2008) Park Relat Disord , vol.14 , Issue.5 , pp. 420-425
    • Trifirò, G.1    Savica, R.2    Morgante, L.3    Vanacore, N.4    Tari, M.5    Moretti, S.6
  • 6
    • 42449142348 scopus 로고    scopus 로고
    • Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal
    • Alacqua M., Trifirò G., Cavagna L., Caporali R., Montecucco C.M., Moretti S., et al. Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. Arthritis Rheum 2008, 59(4):568-574.
    • (2008) Arthritis Rheum , vol.59 , Issue.4 , pp. 568-574
    • Alacqua, M.1    Trifirò, G.2    Cavagna, L.3    Caporali, R.4    Montecucco, C.M.5    Moretti, S.6
  • 7
    • 84918835387 scopus 로고    scopus 로고
    • Chronic kidney disease requiring healthcare services: a new approach to evaluate epidemiology of renal disease
    • Trifirò G., Sultana J., Giorgianni F., Ingrasciotta Y., Buemi M., Muscianisi M., et al. Chronic kidney disease requiring healthcare services: a new approach to evaluate epidemiology of renal disease. Biomed Res Int 2014, 2014:268362.
    • (2014) Biomed Res Int , vol.2014
    • Trifirò, G.1    Sultana, J.2    Giorgianni, F.3    Ingrasciotta, Y.4    Buemi, M.5    Muscianisi, M.6
  • 8
    • 84895799898 scopus 로고    scopus 로고
    • The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy
    • Ingrasciotta Y., Sultana J., Giorgianni F., Caputi A.P., Arcoraci V., Tari D.U., et al. The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS One 2014, 9(2):e89072.
    • (2014) PLoS One , vol.9 , Issue.2
    • Ingrasciotta, Y.1    Sultana, J.2    Giorgianni, F.3    Caputi, A.P.4    Arcoraci, V.5    Tari, D.U.6
  • 9
    • 79957870135 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
    • Isakova T., Wahl P., Vargas G.S., Gutiérrez O.M., Scialla J., Xie H., et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011, 79:1370-1378.
    • (2011) Kidney Int , vol.79 , pp. 1370-1378
    • Isakova, T.1    Wahl, P.2    Vargas, G.S.3    Gutiérrez, O.M.4    Scialla, J.5    Xie, H.6
  • 10
    • 2142746439 scopus 로고    scopus 로고
    • FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
    • Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004, 19(3):429-435.
    • (2004) J Bone Miner Res , vol.19 , Issue.3 , pp. 429-435
    • Shimada, T.1    Hasegawa, H.2    Yamazaki, Y.3    Muto, T.4    Hino, R.5    Takeuchi, Y.6
  • 13
    • 84893488379 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 and cardiovascular events in CKD
    • Chronic Renal Insufficiency Cohort (CRIC) Study Investigators
    • Scialla J.J., Xie H., Rahman M., Anderson A.H., Isakova T., Ojo A., et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 2014, 25:349-360. Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    • (2014) J Am Soc Nephrol , vol.25 , pp. 349-360
    • Scialla, J.J.1    Xie, H.2    Rahman, M.3    Anderson, A.H.4    Isakova, T.5    Ojo, A.6
  • 14
    • 84899737116 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency
    • Jimbo R., Kawakami-Mori F., Mu S., Hirohama D., Majtan B., Shimizu Y., et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency. Kidney Int 2014, 85:1103-1111.
    • (2014) Kidney Int , vol.85 , pp. 1103-1111
    • Jimbo, R.1    Kawakami-Mori, F.2    Mu, S.3    Hirohama, D.4    Majtan, B.5    Shimizu, Y.6
  • 15
    • 79958724181 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
    • Chronic Renal Insufficiency Cohort (CRIC) Study Group
    • Isakova T., Xie H., Yang W., Xie D., Anderson A.H., Scialla J., et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. J Am Med Assoc 2011, 305:2432-2439. Chronic Renal Insufficiency Cohort (CRIC) Study Group.
    • (2011) J Am Med Assoc , vol.305 , pp. 2432-2439
    • Isakova, T.1    Xie, H.2    Yang, W.3    Xie, D.4    Anderson, A.H.5    Scialla, J.6
  • 16
    • 79952604526 scopus 로고    scopus 로고
    • Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis
    • Palmer S.C., Hayen A., Macaskill P., Pellegrini F., Craig J.C., Elder G.J., et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. J Am Med Assoc 2011, 305(11):1119-1127.
    • (2011) J Am Med Assoc , vol.305 , Issue.11 , pp. 1119-1127
    • Palmer, S.C.1    Hayen, A.2    Macaskill, P.3    Pellegrini, F.4    Craig, J.C.5    Elder, G.J.6
  • 17
    • 34248522825 scopus 로고    scopus 로고
    • Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community
    • Dhingra R., Sullivan L.M., Fox C.S., Wang T.J., D'Agostino R.B., Gaziano J.M., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007, 167(9):879-885.
    • (2007) Arch Intern Med , vol.167 , Issue.9 , pp. 879-885
    • Dhingra, R.1    Sullivan, L.M.2    Fox, C.S.3    Wang, T.J.4    D'Agostino, R.B.5    Gaziano, J.M.6
  • 18
    • 84888988021 scopus 로고    scopus 로고
    • Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study
    • George J., Majeed W., Mackenzie I.S., Macdonald T.M., Wei L. Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study. Br Med J 2013, 347:f6954.
    • (2013) Br Med J , vol.347
    • George, J.1    Majeed, W.2    Mackenzie, I.S.3    Macdonald, T.M.4    Wei, L.5
  • 20
    • 84941940052 scopus 로고    scopus 로고
    • Available from: [accessed 20.09.14].
    • European Commission: Enterprise and Industry Directorate-General. Available from: [accessed 20.09.14]. http://ec.europa.eu/health/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf.
  • 21
    • 0141783912 scopus 로고    scopus 로고
    • Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?
    • 2003 May-Jun
    • Uribarri J., Calvo M.S. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?. Semin Dial 2003 May-Jun, 16(3):186-188.
    • Semin Dial , vol.16 , Issue.3 , pp. 186-188
    • Uribarri, J.1    Calvo, M.S.2
  • 24
    • 84937967529 scopus 로고    scopus 로고
    • Serum phosphorus and progression of CKD and mortality: a metaanalysis of cohort studies.
    • Mar 21 00406-0
    • Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y, et al. Serum phosphorus and progression of CKD and mortality: a metaanalysis of cohort studies. Am J Kidney Dis 2015 Mar 21. pii: S0272-6386(15) 00406e0.
    • (2015) Am J Kidney Dis
    • Da, J.1    Xie, X.2    Wolf, M.3    Disthabanchong, S.4    Wang, J.5    Zha, Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.